Background:  TIMPs are so named because they are slow, tight binding endogenous inhibitors of the Matrix Metalloproteinases (MMPs). TIMP-2 is constitutivelyproduced by most cell types in culture, along with MMP-2 (Gelatinase-A). Although TIMP-2 is an efficient inhibitor of MMP-2, it is also required at low concentrations for the activation of MMP-2. It is thought that the MMP-2 is activated by a membrane-bound MMP; and that the TIMP-2 is required to bring the MMP-2 to the cell surface. The four TIMPs have different inhibition constants for the different MMPs studied. TIMP-2 has a greater efficiency against MMP-2, and TIMP-1 works better against MMP-9, MMP-1 and MMP-3. In addition to inhibiting the MMPs, TIMPs have been shown to have activity against the ADAMs family of proteinases. TIMP-3 is an efficient "sheddase" inhibitor, inhibiting ADAM-17 (TACE) at the low nanomolar levels seen with MMP inhibition. The other ADAMs proteinases have not yet been assayed for TIMP inhibition, but TIMP-2 seems to be much less active on ADAM-17 than isTIMP-3. H-TIMP-2 can be used as a positive control in enzymatic assays, ELISA assays, Western blots and substrate gel analysis (reverse zymograms). The TIMP-2 is unglycosylated, about 22 kD in size on reduced Western blots.

Description: Rabbit polyclonal to TIMP2

Immunogen: KLH conjugated synthetic peptide derived from TIMP2

Specificity:  ·Reacts with Human, Mouse and Rat.

·Isotype: IgG

Application:  ·Western blotting: 1/100-500. Predicted Mol wt: 24 kDa;

·Immunohistochemistry (Frozen/paraffin tissue section): 1/50-200;

·Immunocytochemistry: 1/100;

·ELISA: 1/500;

· Optimal working dilutions must be determined by the end user.